Smoking Cessation Strategies Targeting Specific Populations.
- Author:
Eun Mi CHUN
1
Author Information
- Publication Type:Review
- Keywords: Smoking Cessation; Population; Pharmacotherapy
- MeSH: Adolescent; Bupropion; Cardiovascular Diseases; Counseling; Depression; Drug Therapy; Female; Humans; Incidence; Nicotine; Pregnant Women; Pulmonary Disease, Chronic Obstructive; Smoke*; Smoking Cessation*; Smoking*; Tobacco Use Disorder; Varenicline
- From:Tuberculosis and Respiratory Diseases 2019;82(1):1-5
- CountryRepublic of Korea
- Language:English
- Abstract: Quitting smoking helps smokers maintain their health and extend their lifespan by 10 or more years. Treatment strategies for smoking cessation should be tailored to individual smokers with special needs based on their specific circumstances. It is recommended that pregnant women adopt smoking cessation through counseling and behavioral interventions because the safety of medications has yet to be established. Counseling is the main strategy for smoking cessation in adolescents and nicotine replacement therapy can be used with caution in individuals with serious nicotine dependence. It is important for smokers with psychiatric diseases to quit smoking following accurate assessment of their depression status. Nicotine replacement therapy, varenicline, and bupropion can be used for smoking cessation in smokers with psychiatric disorders. The incidence of cardiovascular disease decreased according to the smoking status and the duration of smoking cessation. In smokers with chronic obstructive pulmonary disease (COPD) who used a combination of counseling and pharmacotherapy the quitting rate was more than twice as high as subjects who used behavioral interventions alone. Varenicline can be used as the most effective anti-smoking drug by most smokers including those with psychiatric disorders, cardiovascular disease, and COPD.
